French consensus procedure for neuropsychological assessment in multiple sclerosis.

IF 2.8 4区医学 Q2 CLINICAL NEUROLOGY Revue neurologique Pub Date : 2024-07-12 DOI:10.1016/j.neurol.2024.06.005

C Jougleux, H Joly, H Brissard, B Lenne, S François, F Hamelin, N Derache, J Morin, F Reuter, R Colamarino, A Ruet

{"title":"French consensus procedure for neuropsychological assessment in multiple sclerosis.","authors":"C Jougleux, H Joly, H Brissard, B Lenne, S François, F Hamelin, N Derache, J Morin, F Reuter, R Colamarino, A Ruet","doi":"10.1016/j.neurol.2024.06.005","DOIUrl":null,"url":null,"abstract":"<p><p>Cognitive impairment is one of the invisible symptoms of Multiple sclerosis (MS), which could be associated with depression, unemployment, reduced social interaction, inability to drive, and compromised quality of life. Moreover, the presence of cognitive impairment can be considered as a long-term prognostic factor and in the follow-up of disability. So, cognitive assessment is a crucial element in clinical follow-up of patients with MS (pwMS). International recommendations mention the use of the Brief International Cognitive Assessment in MS (BICAMS). The BICAMS, that has been recently validated in French is a brief non-exhaustive assessment, developed as a short screening battery, hence needing other supplemented tests. The present paper aims to propose a consensus, approved by expert French consensus from the Cognition group of the SF-SEP (http://sfsep.org [Société Francophone de la Sclérose en Plaques]), for cognitive assessment of pwMS suggesting the tools that should be used in order to apprehend the other cognitive impairments that could appear in MS.</p>","PeriodicalId":21321,"journal":{"name":"Revue neurologique","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue neurologique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.neurol.2024.06.005","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Cognitive impairment is one of the invisible symptoms of Multiple sclerosis (MS), which could be associated with depression, unemployment, reduced social interaction, inability to drive, and compromised quality of life. Moreover, the presence of cognitive impairment can be considered as a long-term prognostic factor and in the follow-up of disability. So, cognitive assessment is a crucial element in clinical follow-up of patients with MS (pwMS). International recommendations mention the use of the Brief International Cognitive Assessment in MS (BICAMS). The BICAMS, that has been recently validated in French is a brief non-exhaustive assessment, developed as a short screening battery, hence needing other supplemented tests. The present paper aims to propose a consensus, approved by expert French consensus from the Cognition group of the SF-SEP (http://sfsep.org [Société Francophone de la Sclérose en Plaques]), for cognitive assessment of pwMS suggesting the tools that should be used in order to apprehend the other cognitive impairments that could appear in MS.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

法国多发性硬化症神经心理学评估共识程序。

认知障碍是多发性硬化症（MS）的隐形症状之一，可能与抑郁、失业、社交减少、无法驾驶和生活质量下降有关。此外，认知障碍的存在可被视为长期预后因素和残疾随访因素。因此，认知评估是对多发性硬化症患者（pwMS）进行临床随访的关键因素。国际建议提及使用多发性硬化症简明国际认知评估（BICAMS）。BICAMS 最近在法国得到了验证，它是一种简短而非详尽的评估方法，作为一种简短的筛查方法而开发，因此需要其他辅助测试。本文旨在提出一项共识，该共识得到了 SF-SEP (http://sfsep.org [Société Francophone de la Sclérose en Plaques])认知小组法国专家的认可，该共识建议使用哪些工具来对多发性硬化症患者可能出现的其他认知障碍进行认知评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Revue neurologique 医学-临床神经学

CiteScore

4.80

自引率

0.00%

发文量

598

审稿时长

55 days

期刊介绍： The first issue of the Revue Neurologique, featuring an original article by Jean-Martin Charcot, was published on February 28th, 1893. Six years later, the French Society of Neurology (SFN) adopted this journal as its official publication in the year of its foundation, 1899. The Revue Neurologique was published throughout the 20th century without interruption and is indexed in all international databases (including Current Contents, Pubmed, Scopus). Ten annual issues provide original peer-reviewed clinical and research articles, and review articles giving up-to-date insights in all areas of neurology. The Revue Neurologique also publishes guidelines and recommendations. The Revue Neurologique publishes original articles, brief reports, general reviews, editorials, and letters to the editor as well as correspondence concerning articles previously published in the journal in the correspondence column.

期刊最新文献

Editorial Board Contents CAR T-cell-associated neurotoxicity: A comprehensive review The immunology underlying CNS autoantibody diseases 40 years of autoantibody research in paraneoplastic neurological syndromes